Correlation Between Handa Pharmaceuticals and Lotus Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Handa Pharmaceuticals and Lotus Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Handa Pharmaceuticals and Lotus Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Handa Pharmaceuticals and Lotus Pharmaceutical Co, you can compare the effects of market volatilities on Handa Pharmaceuticals and Lotus Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Handa Pharmaceuticals with a short position of Lotus Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Handa Pharmaceuticals and Lotus Pharmaceutical.
Diversification Opportunities for Handa Pharmaceuticals and Lotus Pharmaceutical
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Handa and Lotus is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Handa Pharmaceuticals and Lotus Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lotus Pharmaceutical and Handa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Handa Pharmaceuticals are associated (or correlated) with Lotus Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lotus Pharmaceutical has no effect on the direction of Handa Pharmaceuticals i.e., Handa Pharmaceuticals and Lotus Pharmaceutical go up and down completely randomly.
Pair Corralation between Handa Pharmaceuticals and Lotus Pharmaceutical
Assuming the 90 days trading horizon Handa Pharmaceuticals is expected to generate 9.21 times less return on investment than Lotus Pharmaceutical. In addition to that, Handa Pharmaceuticals is 1.2 times more volatile than Lotus Pharmaceutical Co. It trades about 0.02 of its total potential returns per unit of risk. Lotus Pharmaceutical Co is currently generating about 0.18 per unit of volatility. If you would invest 25,750 in Lotus Pharmaceutical Co on August 26, 2024 and sell it today you would earn a total of 2,400 from holding Lotus Pharmaceutical Co or generate 9.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Handa Pharmaceuticals vs. Lotus Pharmaceutical Co
Performance |
| Timeline |
| Handa Pharmaceuticals |
| Lotus Pharmaceutical |
Handa Pharmaceuticals and Lotus Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Handa Pharmaceuticals and Lotus Pharmaceutical
The main advantage of trading using opposite Handa Pharmaceuticals and Lotus Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Handa Pharmaceuticals position performs unexpectedly, Lotus Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lotus Pharmaceutical will offset losses from the drop in Lotus Pharmaceutical's long position.| Handa Pharmaceuticals vs. Lotus Pharmaceutical Co | Handa Pharmaceuticals vs. Center Laboratories | Handa Pharmaceuticals vs. Synmosa Biopharma | Handa Pharmaceuticals vs. GeneFerm Biotechnology Co |
| Lotus Pharmaceutical vs. Center Laboratories | Lotus Pharmaceutical vs. Synmosa Biopharma | Lotus Pharmaceutical vs. GeneFerm Biotechnology Co | Lotus Pharmaceutical vs. Alar Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |